BRIMOCHOL PF, a preservative-free eyedrop, successfully met the pre-specified visual acuity primary endpoints for both the US and EU/UK against its active comparators carbachol and brimonidine.

BRIMOCHOL PF successfully demonstrated “contribution-of-elements,” paving the way for the first, and potentially only, fixed-dose combination topical ophthalmic eyedrop for Presbyopia.

BRIMOCHOL PF achieved highly statistically significant near vision improvements over 8 hours and was…